EMEA-002127-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Recombinant humanised IgG4 monoclonal antibody against MSRV-Envelope protein (GNbAC1)

Decision numberP/0371/2017
PIP numberEMEA-002127-PIP01-17
Pharmaceutical form(s)Solution for infusion
Condition(s)/indication(s)

Treatment of multiple sclerosis

Route(s) of administrationIntravenous use
PIP applicant

GeNeuro SA
Tel. +41  225524800
E-mail: contact@geneuro.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision